| High grade serous ovarian carcinomas originate in the fallopian tube SI Labidi-Galy, E Papp, D Hallberg, N Niknafs, V Adleff, M Noe, ... Nature communications 8 (1), 1093, 2017 | 687 | 2017 |
| Cancer-associated mutations in endometriosis without cancer MS Anglesio, N Papadopoulos, A Ayhan, TM Nazeran, M Noë, ... New England Journal of Medicine 376 (19), 1835-1848, 2017 | 591 | 2017 |
| Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma KT Kuo, TL Mao, S Jones, E Veras, A Ayhan, TL Wang, R Glas, D Slamon, ... The American journal of pathology 174 (5), 1597-1601, 2009 | 538 | 2009 |
| The inflammatory cytokine tumor necrosis factor-α generates an autocrine tumor-promoting network in epithelial ovarian cancer cells H Kulbe, R Thompson, JL Wilson, S Robinson, T Hagemann, R Fatah, ... Cancer research 67 (2), 585-592, 2007 | 512 | 2007 |
| Mature cystic teratomas of the ovary: case series from one institution over 34 years A Ayhan, O Bukulmez, C Genc, BS Karamursel, A Ayhan European Journal of Obstetrics & Gynecology and reproductive biology 88 (2 …, 2000 | 358 | 2000 |
| Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma A Ayhan, TL Mao, T Seckin, CH Wu, B Guan, H Ogawa, M Futagami, ... International Journal of Gynecologic Cancer 22 (8), 2012 | 192 | 2012 |
| Cystic and adenofibromatous clear cell carcinomas of the ovary: distinctive tumors that differ in their pathogenesis and behavior: a clinicopathologic analysis of 122 cases E Veras, TL Mao, A Ayhan, S Ueda, H Lai, M Hayran, IM Shih, RJ Kurman The American journal of surgical pathology 33 (6), 844-853, 2009 | 182 | 2009 |
| Inhibition of spleen tyrosine kinase potentiates paclitaxel-induced cytotoxicity in ovarian cancer cells by stabilizing microtubules Y Yu, S Gaillard, JM Phillip, TC Huang, SM Pinto, NG Tessarollo, Z Zhang, ... Cancer cell 28 (1), 82-96, 2015 | 168 | 2015 |
| Increased expression of p34cdc2 and its kinase activity in human gastric and colonic carcinomas W Yasui, A Ayhan, Y Kitadai, K Nishimura, H Yokozaki, HI And, E Tahara International journal of cancer 53 (1), 36-41, 1993 | 161 | 1993 |
| A role for endothelin-2 and its receptors in breast tumor cell invasion MJ Grimshaw, T Hagemann, A Ayhan, CE Gillett, C Binder, FR Balkwill Cancer Research 64 (7), 2461-2468, 2004 | 151 | 2004 |
| Genetic intra‐tumour heterogeneity in epithelial ovarian cancer and its implications for molecular diagnosis of tumours L Khalique, A Ayhan, ME Weale, IJ Jacobs, SJ Ramus, SA Gayther The Journal of Pathology: A Journal of the Pathological Society of Great …, 2007 | 126 | 2007 |
| Temel kadın hastalıkları ve doğum bilgisi A Ayhan, T Durukan, S Günalp, T Gürgan, LS Önderoğlu, H Yaralı, K Yüce Baskı, Ankara, Güneş Tıp Kitapevi, 2008 | 117 | 2008 |
| Expression of epidermal growth factor in human tissues: immunohistochemical and biochemical analysis K Kajikawa, W Yasui, H Sumiyoshi, K Yoshida, H Nakayama, A Ayhan, ... Virchows Archiv A 418, 27-32, 1991 | 111 | 1991 |
| Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy RC Wu, A Ayhan, D Maeda, KR Kim, BA Clarke, P Shaw, MH Chui, ... The Journal of pathology 232 (4), 473-481, 2014 | 110 | 2014 |
| Defining the cut point between low-grade and high-grade ovarian serous carcinomas: a clinicopathologic and molecular genetic analysis A Ayhan, RJ Kurman, A Yemelyanova, R Vang, S Logani, JD Seidman, ... The American journal of surgical pathology 33 (8), 1220-1224, 2009 | 108 | 2009 |
| Overexpression of the c-Met/HGF receptor and its prognostic significance in uterine cervix carcinomas C Baykal, A Ayhan, A Al, K Yüce, A Ayhan Gynecologic oncology 88 (2), 123-129, 2003 | 108 | 2003 |
| p53 point mutations in primary human gastric carcinomas H Yokozaki, H Kuniyasu, Y Kitadai, K Nishimura, H Todo, A Ayhan, ... Journal of cancer research and clinical oncology 119, 67-70, 1992 | 108 | 1992 |
| A logistic regression model including DNA status and morphology of spermatozoa for prediction of fertilization in vitro. EH Duran, T Gürgan, S Günalp, ME Enginsu, H Yarali, A Ayhan Human reproduction (Oxford, England) 13 (5), 1235-1239, 1998 | 106 | 1998 |
| Loss of ARID1A expression correlates with stages of tumor progression in uterine endometrioid carcinoma TL Mao, L Ardighieri, A Ayhan, KT Kuo, CH Wu, TL Wang, IM Shih The American journal of surgical pathology 37 (9), 1342-1348, 2013 | 105 | 2013 |
| Loss of ARID1A in tumor cells renders selective vulnerability to combined ionizing radiation and PARP inhibitor therapy Y Park, MH Chui, Y Suryo Rahmanto, ZC Yu, RA Shamanna, MA Bellani, ... Clinical Cancer Research 25 (18), 5584-5594, 2019 | 100 | 2019 |
Ie-Ming ShihJohns Hopkins University Department of Gynecology and Obstetrics在 jhmi.edu 的电子邮件经过验证
